GNWRX
Price
$32.26
Change
+$0.31 (+0.97%)
Updated
Jul 3 closing price
Net Assets
1.77B
VSMPX
Price
$281.45
Change
+$2.40 (+0.86%)
Updated
Jul 3 closing price
Net Assets
1.82T
Interact to see
Advertisement

GNWRX vs VSMPX

Header iconGNWRX vs VSMPX Comparison
Open Charts GNWRX vs VSMPXBanner chart's image
Nationwide R
Price$32.26
Change+$0.31 (+0.97%)
VolumeN/A
Net Assets1.77B
Vanguard Total Stock Mkt Idx Instl Pls
Price$281.45
Change+$2.40 (+0.86%)
VolumeN/A
Net Assets1.82T
GNWRX vs VSMPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GNWRX vs. VSMPX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNWRX is a Buy and VSMPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 1.82T vs. GNWRX (1.77B). VSMPX pays higher dividends than GNWRX: VSMPX (1.22) vs GNWRX (0.00). GNWRX was incepted earlier than VSMPX: GNWRX (22 years) vs VSMPX (10 years). GNWRX (1.34) is less costly to investors than VSMPX (0.02). GNWRX is a more actively managed with annual turnover of: 83.61 vs. VSMPX (2.00). GNWRX has a lower initial minimum investment than VSMPX: GNWRX (0) vs VSMPX (100000000). VSMPX annual gain was more profitable for investors over the last year : 13.90 vs. GNWRX (1.03). VSMPX return over 5 years is better than : 95.69 vs. GNWRX (42.22).
GNWRXVSMPXGNWRX / VSMPX
Total Expense Ratio1.300.026,500%
Annual Report Gross Expense Ratio1.340.026,700%
Fund Existence22 years10 years-
Gain YTD6.4346.426100%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.77B1.82T0%
Annual Yield % from dividends0.001.22-
Returns for 1 year1.0313.907%
Returns for 3 years37.4462.1760%
Returns for 5 years42.2295.6944%
Returns for 10 years47.50189.2125%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRIB0.750.07
+10.12%
Trinity Biotech plc
CATX3.680.29
+8.55%
Perspective Therapeutics
CGEN1.760.02
+1.15%
Compugen Ltd
STT110.310.82
+0.75%
State Street Corp
WHD45.270.01
+0.02%
Cactus